CCDC102B confers risk of low vision and blindness in high myopia

CCDC102B会增加高度近视患者出现低视力甚至失明的风险

阅读:3
作者:Yoshikatsu Hosoda,Munemitsu Yoshikawa,Masahiro Miyake,Yasuharu Tabara,Noriaki Shimada,Wanting Zhao,Akio Oishi,Hideo Nakanishi,Masayuki Hata,Tadamichi Akagi,Sotaro Ooto,Natsuko Nagaoka,Yuxin Fang,Ryo Yamada,Fumihiko Matsuda,Akitaka Tsujikawa,Kenji Yamashiro

Abstract

The incidence of high myopia is increasing worldwide with myopic maculopathy, a complication of myopia, often progressing to blindness. Our two-stage genome-wide association study of myopic maculopathy identifies a susceptibility locus at rs11873439 in an intron of CCDC102B (P = 1.77 × 10-12 and Pcorr = 1.61 × 10-10). In contrast, this SNP is not significantly associated with myopia itself. The association between rs11873439 and myopic maculopathy is further confirmed in 2317 highly myopic patients (P = 2.40 × 10-6 and Pcorr = 1.72 × 10-4). CCDC102B is strongly expressed in the retinal pigment epithelium and choroids, where atrophic changes initially occur in myopic maculopathy. The development of myopic maculopathy thus likely exhibits a unique background apart from the development of myopia itself; elucidation of the roles of CCDC102B in myopic maculopathy development may thus provide insights into preventive methods for blindness in patients with high myopia.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。